Rothschild Investment LLC Madrigal Pharmaceuticals, Inc. Transaction History
Rothschild Investment LLC
- $1.53 Trillion
- Q4 2024
A detailed history of Rothschild Investment LLC transactions in Madrigal Pharmaceuticals, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 20 shares of MDGL stock, worth $6,654. This represents 0.0% of its overall portfolio holdings.
Number of Shares
20
Previous 17
17.65%
Holding current value
$6,654
Previous $3.61 Million
71.04%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding MDGL
# of Institutions
303Shares Held
22MCall Options Held
819KPut Options Held
644K-
Janus Henderson Group PLC London, X02.48MShares$825 Million0.28% of portfolio
-
John Paulson Paulson & Co. Inc. | New York, Ny2.04MShares$679 Million29.57% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.03MShares$675 Million6.48% of portfolio
-
Rtw Investments, LP New York, NY1.99MShares$663 Million6.74% of portfolio
-
Baker Bros. Advisors LP New York, NY1.97MShares$657 Million4.49% of portfolio
About MADRIGAL PHARMACEUTICALS, INC.
- Ticker MDGL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,103,400
- Market Cap $5.69B
- Description
- Madrigal Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III c...